Articles from Starlab Space

Starlab Space LLC, the commercial space station developer expanding access to low Earth orbit research, today announced a reservation agreement with LambdaVision, a biotechnology company developing a protein-based artificial retina designed to restore vision for patients with retinal degenerative diseases. The reservation agreement supports LambdaVision’s transition from research to long-term, scalable biomedical production in space and ensures its continued access to microgravity as the International Space Station approaches retirement.

Starlab Space LLC, developer of a next-generation commercial space station, has successfully completed its Commercial Critical Design Review (CCDR) with NASA in attendance, marking a decisive transition from design to manufacturing and systems integration. The CCDR data supports the 28th milestone on the NASA Commercial LEO Destinations Space Act Agreement.